Cart
sales@molnova.com
Nilofabicin
CAS No. 934628-27-0
Nilofabicin( CG-400549 | CG 400549 | CG400549 | CG-0549 | CG 0549 | CG0549 | )
Catalog No. M27115 CAS No. 934628-27-0
Nilofabicin is a potent inhibitor of enoyl-(acyl-carrier-protein) reductase fall(FabI) and can be used in studies about the treatment of complicated acute.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 36 | In Stock |
|
| 5MG | 31 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 74 | In Stock |
|
| 50MG | 116 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNilofabicin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNilofabicin is a potent inhibitor of enoyl-(acyl-carrier-protein) reductase fall(FabI) and can be used in studies about the treatment of complicated acute.
-
DescriptionNilofabicin is a potent inhibitor of enoyl-(acyl-carrier-protein) reductase fall(FabI) and can be used in studies about the treatment of complicated acute. (In Vitro):Nilofabicin had an MIC90 of 0.5 μg/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin. Among 203 strains of Staphylococcus aureus, the MICs of Nilofabicin were 0.06 to 1.0 μg/ml, with MIC(50) and MIC(90) values of 0.25 μg/ml each. All strains were susceptible to linezolid and quinupristin-dalfopristin (MICs, 0.25 to 2.0 μg/ml).
-
In Vitro——
-
In Vivo——
-
SynonymsCG-400549 | CG 400549 | CG400549 | CG-0549 | CG 0549 | CG0549 |
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorProstacyclin receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number934628-27-0
-
Formula Weight340.44
-
Molecular FormulaC19H20N2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (293.74 mM)
-
SMILESCc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bexis S, et, al. Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat. Eur J Pharmacol. 2008 Aug 20;590(1-3):322-6.
molnova catalog
related products
-
F1063-0967
F1063-0967 is a Dual-specificity phosphatase 26 (DUSP26) inhibitor with an IC50 of 11.62 μM.
-
Polyoxyethylene stea...
Polyoxyethylene stearate is an agent of non-ionic emulsifying.
-
Moxifloxacin
A fourth-generation synthetic fluoroquinolone, broad-spectrum antibacterial agent that is active against both Gram-positive and Gram-negative bacteria.
